The publisher, the industry analysis specialist, has released its latest report “Jordan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Jordan. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.
Jordan is regarded as one of the most prominent medical tourism destinations in the Middle East and is a front-runner in pharmaceutical production in the Middle East and North Africa (MENA) region. As a result of factors like increased medical tourism from Saudi Arabia and other Gulf Cooperation Council (GCC) nations, Jordan is expected to experience further growth in the coming years. Jordan's pharmaceutical market, in terms of US dollars, was worth $0.91 billion in 2014, which was expected to increase at a Compound Annual Growth Rate (CAGR) of 3.5% to $1.16 billion in 2021. The market value is expected to grow further and is forecast to reach $1.42 billion by 2027. The growth of the pharmaceutical market is attributed to the medical tourism sector, an aging population, the associated disease burden, and exports. Jordan's medical devices market was expected to grow at a CAGR of 9.3% from $244 million in 2015 to $595 million in 2021. It is expected to reach $1.5 billion by 2027. The demand for medical supplies and services is influenced by several factors, including the expansion of health insurance coverage, the construction of new hospitals and medical facilities, the development of pre-existing hospitals, and the switch from traditional treatments to modern ones. The Ministry Strategy 2020-24 aims to safely digitalize the Jordanian economy. Through this strategy, the government of Jordan is focusing on the development of the National Fiber Optic Network Program, which will help link all the government, health, and education agencies of various regions of the nation.
Jordan is regarded as one of the most prominent medical tourism destinations in the Middle East and is a front-runner in pharmaceutical production in the Middle East and North Africa (MENA) region. As a result of factors like increased medical tourism from Saudi Arabia and other Gulf Cooperation Council (GCC) nations, Jordan is expected to experience further growth in the coming years. Jordan's pharmaceutical market, in terms of US dollars, was worth $0.91 billion in 2014, which was expected to increase at a Compound Annual Growth Rate (CAGR) of 3.5% to $1.16 billion in 2021. The market value is expected to grow further and is forecast to reach $1.42 billion by 2027. The growth of the pharmaceutical market is attributed to the medical tourism sector, an aging population, the associated disease burden, and exports. Jordan's medical devices market was expected to grow at a CAGR of 9.3% from $244 million in 2015 to $595 million in 2021. It is expected to reach $1.5 billion by 2027. The demand for medical supplies and services is influenced by several factors, including the expansion of health insurance coverage, the construction of new hospitals and medical facilities, the development of pre-existing hospitals, and the switch from traditional treatments to modern ones. The Ministry Strategy 2020-24 aims to safely digitalize the Jordanian economy. Through this strategy, the government of Jordan is focusing on the development of the National Fiber Optic Network Program, which will help link all the government, health, and education agencies of various regions of the nation.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Jordan, and includes:- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Sanofi, Novartis, GSK, and JPM.
- Profiles and SWOT analyses of the major players in the medical device market: Roche, Abbott, Medtronic, Fresenius, and Stryker.
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
- Detailed analysis of the country's healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in Jordanian healthcare market.
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:- Develop business strategies by understanding the trends shaping and driving Jordanian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Jordanian healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
1. Table of Contents1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights: Facts About the Jordanian Healthcare Market
2.3 Key Highlights: Healthcare Startups in Jordan
2.4 Key Events: Jordanian Healthcare Timeline, 2016-22
2.5 Key Events: Jordanian Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2021-22
2.7 Key Events: Top Completed Deals by Value, 2022
2.8 Country Profile, Jordan, 2021
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Jordan
3.5 Pharmaceutical Market - Medical Tourism, Jordan
3.6 Pharmaceutical Market - Market Segments
3.7 COVID-19 Epidemiology, Jordan
3.8 COVID-19 Impact and Developments in the Healthcare Market, Jordan
3.9 COVID-19 Clinical Trials Landscape, Jordan
3.10 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Jordan, 2020-22
6.2 Deal Analysis: Medical Devices Market, Jordan, 2020-22
7. HealthTech Landscape
7.1 HealthTech Landscape, Jordan
7.2 Key Healthtech Deals, Jordan
7.3 Adoption of Technology in Healthcare, Jordan
7.4 Digital Regulations, Jordan
7.5 HealthTech Landscape: Benefits and Risks, Jordan
8. Market Access
8.1 Overview of Healthcare System, Jordan
8.2 Reimbursement Landscape, Jordan
8.3 Overview of Insurance Providers, Jordan
8.4 Healthcare Spending and Prescription Drug Price Trend, Jordan
8.5 Pricing Policies, Jordan
8.6 Market Access: Key Events Timeline, Jordan, 2010-22
8.7 Regulatory Landscape, Jordan
8.7.1 Marketing Authorization for Pharmaceutical Products, Jordan
8.7.2 Marketing Authorization for Medical Devices, Jordan
8.7.3 Intellectual Property Rights, Patents, Jordan
8.7.4 Intellectual Property Rights, Trademark, Jordan
8.7.5 Clinical Trial Regulations, Jordan
8.7.6 Pharmaceutical Clinical Trials Landscape, Jordan
8.7.7 Medical Devices Clinical Trials Landscape, Jordan
8.7.8 Pharmaceutical Imports and Exports, Jordan
8.7.9 Pharmaceutical Advertising Regulations, Jordan
8.7.10 Pharmacy Regulations, Jordan
8.7.11 Labeling and Packaging Regulations, Jordan
9. Country Healthcare Landscape
9.1 Jordanian Healthcare Policy Highlights
9.2 Healthcare Facilities, Jordan
9.3 Life Expectancy and Immunization Rate, Jordan
9.4 Environmental Health, Jordan
9.5 Healthcare Personnel, Jordan
9.6 Disease Burden, Jordan
9.7 Healthcare Expenditure, Jordan
10 Trade Associations, Jordan
11 Trade Fairs, Jordan
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer
List of Tables
Table 1: COVID-19 indicators (number of cases), global and Jordan, 2022
Table 2: Approved vaccines, Jordan, 2022
Table 3: Patent fee, Jordan, 2022
Table 4: Trademark fees, Jordan, 2022
Table 5: Label on the blister package, Jordan, 2022
Table 6: Product insert (leaflet) information, Jordan, 2022
Table 7: Label of small pack, Jordan, 2022
Table 8: Trade fairs, Jordan, 2022
List of Figures
Figure 1: Pharmaceutical market, revenue ($B), Jordan, 2014-21
Figure 2: Medical devices market, revenue ($M), Jordan, 2015-21
Figure 3: Healthcare start-ups in Jordan, 2022
Figure 4: Country profile, Jordan, 2021
Figure 5: Pharmaceutical market, revenue ($B), Jordan, 2012-21
Figure 6: Pharmaceutical market, revenue forecast ($M), Jordan, 2022-27
Figure 7: Pharmaceutical exports ($B), Jordan, 2014-20
Figure 8: Top export partners, Jordan, 2020
Figure 9: Pharmaceutical imports ($M), Jordan, 2014-20
Figure 10: Top import partners, Jordan, 2020
Figure 11: MOH drug distribution process, Jordan, 2022
Figure 12: Private sector drug distribution process, Jordan, 2022
Figure 13: Public sector drug procurement process, Jordan, 2022
Figure 14: Reasons to travel to Jordan for medical treatment, 2022
Figure 15: COVID-19 cases, Jordan, 2020-22
Figure 16: COVID-19 deaths, Jordan, 2020-22
Figure 17: COVID-19 stringency index (based on the share of people who are vaccinated), Jordan, 2020-22
Figure 18: COVID-19 containment and health index, Jordan, 2020-22
Figure 19: COVID-19 clinical trials count by trial status, Jordan, 2020-22
Figure 20: COVID-19 clinical trials count by trial phase, Jordan, 2020-22
Figure 21: Top COVID-19 clinical trials sponsors by trial count, Jordan, 2020-22
Figure 22: Medical devices market, revenue ($M), Jordan, 2015-21
Figure 23: Medical devices market, revenue forecast ($M), Jordan, 2022-27
Figure 24: Medical devices market, revenue ($B) of major companies, Jordan, 2021
Figure 25: Deal value and deal count, pharmaceutical market, Jordan, 2020-22
Figure 26: Deal value and deal count subtypes, pharmaceutical market, Jordan, 2020-22
Figure 27: Deal value and deal count, quarterly, pharmaceutical market, Jordan, 2020-22
Figure 28: Top therapy areas by deal value ($M), pharmaceutical market, Jordan, 2020-22
Figure 29: Top therapy areas by deal count, pharmaceutical market, Jordan, 2020-22
Figure 30: Deal value and deal count, medical devices market, Jordan, 2020-22
Figure 31: Deal value and deal count subtypes, medical devices market, Jordan, 2020-22
Figure 32: Deal value and deal count, quarterly, medical devices market, Jordan, 2019-22
Figure 33: Top equipment sectors by deal value ($M), medical devices market, Jordan, 2020-22
Figure 34: Top equipment sectors by deal count, medical devices market, Jordan, 2020-22
Figure 35: M&A deals by quarter, medical devices market, Jordan, 2020-22 (by value and by number)
Figure 36: VC deals by quarter, medical devices market, Jordan, 2020-22 (by value and by number)
Figure 37: Core values of the ministry of digital economy and entrepreneurship, Jordan, 2022
Figure 38: Key performance indicators as per the national digital transformation strategy and implementation plan 2021-25, Jordan
Figure 39: Emerging technologies as per the national digital transformation strategy and implementation plan 2021-25, Jordan
Figure 40: Strength enablers as per the national digital transformation strategy and implementation plan 2021-25, Jordan
Figure 41: Digital transformation timeline as per the national digital transformation strategy and implementation plan 2021-25, Jordan
Figure 42: Overview of healthcare system, Jordan, 2022
Figure 43: Categories covered by military health insurance, Jordan, 2022
Figure 44: Timeline of civil health insurance, Jordan, 2022
Figure 45: OOP expenditure (% of total expenditure on health), Jordan, 2011-22
Figure 46: Consumer price index, monthly price index numbers (2018=100), Jordan, 2022
Figure 47: Countries referred for calculating the drug pricing through the median method, Jordan, 2022
Figure 48: Organization structure of regulatory agencies, Jordan, 2022
Figure 49: Drug application type selection, Jordan, 2022
Figure 50: Medical device approval process, Jordan, 2022
Figure 51: Patent approval process, Jordan, 2022
Figure 52: Trademark approval process, Jordan, 2022
Figure 53: Pharmaceutical clinical trials count by trial status, Jordan, 2020-22 and by number
Figure 54: Pharmaceutical clinical trials count by therapy areas, Jordan, 2020-22
Figure 55: Pharmaceutical clinical trials count by phase, Jordan, 2020-22
Figure 56: Top five pharmaceutical clinical trial sponsors by count, Jordan, 2020-22
Figure 57: Medical devices clinical trials count by trial status, Jordan, 2020-22
Figure 58: Medical devices clinical trials count by therapy areas, Jordan, 2020-22
Figure 59: Medical devices clinical trials count by market categories, Jordan, 2020-22
Figure 60: Top medical devices clinical trials sponsors by count, Jordan, 2020-22
Figure 61: Number of hospitals, Jordan, 2016-21
Figure 62: Number of hospital beds per 10,000 population, Jordan, 2013-21
Figure 63: Life expectancy at birth (years), Jordan, 2013-20
Figure 64: Immunization rate (%), Jordan, 2013-20
Figure 65: PM2.5 (µg per m3), Jordan, 2013-19
Figure 66: CO2 emissions (metric tons per capita), Jordan, 2013-20
Figure 67: Physicians (per 10,000 population), Jordan, 2013-21
Figure 68: Pharmacists (per 10,000 population), Jordan, 2013-21
Figure 69: Dentists (per 10,000 population), Jordan, 2013-21
Figure 70: Nurses and midwives (per 10,000 population), Jordan, 2013-21
Figure 71: Major causes of mortality (per 100,000 population), Jordan, 2019
Figure 72: Major causes of male mortality (per 100,000 population), Jordan, 2019
Figure 73: Major causes of female mortality (per 100,000 population), Jordan, 2019
Figure 74: DALYs by major disease (per 100,000 population), Jordan, 2019
Figure 75: Healthcare expenditure as percentage of GDP (%), Jordan, 2013-19
Figure 76: Health expenditure share (% of current health spending), Jordan, 2013-19
